Tenon Medical (TNON) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.70, -7.22% vs the prior close of $2.91.
- Volume 210.69K shares, 0.0x its 50-day average (light).
- New SEC filings: 424B5 (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
TNON slides 7.2% to $2.70, a 1-month low. Closed at $2.70, -7.22% vs the prior close of $2.91. Day range $2.67β$3.05, opened at $2.95.
TNON daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β TNON slides 7.2% to $2.70, a 1-month low
- Closed at $2.70, -7.22% vs the prior close of $2.91. Day range $2.67β$3.05, opened at $2.95.
- Volume was 210.69K shares, 0.0x its 50-day average of 8.21M β lighter than usual.
- Price is -39.5% vs its 50-day average ($4.46) and -85.5% vs its 200-day average ($18.68).
- 52-week range $2.40β$50.40; today's close sits at 1% of that range, 94.6% below the 52-week high.
Oct 15, 2026 β TNON jumps 3.2% to $2.91
- Closed at $2.91, +3.19% vs the prior close of $2.82. Day range $2.78β$2.93, opened at $2.83.
- Volume was 149.90K shares, 0.0x its 50-day average of 8.20M β lighter than usual.
- Price is -35.7% vs its 50-day average ($4.53) and -84.6% vs its 200-day average ($18.84).
- 52-week range $2.40β$50.40; today's close sits at 1% of that range, 94.2% below the 52-week high.
Oct 14, 2026 β TNON dips 2.4% to $2.82, 6 down days in a row
- Closed at $2.82, -2.42% vs the prior close of $2.89. Day range $2.80β$2.94, opened at $2.82.
- Volume was 157.10K shares, 0.0x its 50-day average of 8.21M β lighter than usual.
- Price is -38.8% vs its 50-day average ($4.60) and -85.2% vs its 200-day average ($19.01).
- 52-week range $2.40β$50.40; today's close sits at 1% of that range, 94.4% below the 52-week high.
- That makes 6 straight losses.
Oct 13, 2026 β TNON slides 3.0% to $2.89, 5 down days in a row
- Closed at $2.89, -3.02% vs the prior close of $2.98. Day range $2.85β$3.10, opened at $2.98.
- Volume was 225.90K shares, 0.0x its 50-day average of 8.20M β lighter than usual.
- Price is -38.3% vs its 50-day average ($4.68) and -84.9% vs its 200-day average ($19.18).
- 52-week range $2.40β$50.40; today's close sits at 1% of that range, 94.3% below the 52-week high.
- That makes 5 straight losses.
Oct 12, 2026 β TNON slides 12.6% to $2.98, 4 down days in a row
- Closed at $2.98, -12.61% vs the prior close of $3.41. Day range $2.95β$3.36, opened at $3.34.
- Volume was 262.70K shares, 0.0x its 50-day average of 8.20M β lighter than usual.
- Price is -37.4% vs its 50-day average ($4.76) and -84.6% vs its 200-day average ($19.35).
- 52-week range $2.40β$50.40; today's close sits at 1% of that range, 94.1% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 β TNON dips 0.9% to $3.41, 3 down days in a row
- Closed at $3.41, -0.87% vs the prior close of $3.44. Day range $3.37β$3.52, opened at $3.41.
- Volume was 129.90K shares, 0.0x its 50-day average of 8.19M β lighter than usual.
- Price is -29.5% vs its 50-day average ($4.84) and -82.5% vs its 200-day average ($19.52).
- 52-week range $2.40β$50.40; today's close sits at 2% of that range, 93.2% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 β TNON dips 1.7% to $3.44
- Closed at $3.44, -1.71% vs the prior close of $3.50. Day range $3.42β$3.58, opened at $3.46.
- Volume was 111.10K shares, 0.0x its 50-day average of 8.19M β lighter than usual.
- Price is -29.9% vs its 50-day average ($4.91) and -82.5% vs its 200-day average ($19.69).
- 52-week range $2.40β$50.40; today's close sits at 2% of that range, 93.2% below the 52-week high.
Oct 7, 2026 β TNON slides 5.8% to $3.50
- Closed at $3.50, -5.79% vs the prior close of $3.71. Day range $3.38β$3.64, opened at $3.58.
- Volume was 355.00K shares, 0.0x its 50-day average of 8.18M β lighter than usual.
- Price is -29.6% vs its 50-day average ($4.97) and -82.4% vs its 200-day average ($19.87).
- 52-week range $2.40β$50.40; today's close sits at 2% of that range, 93.1% below the 52-week high.
Oct 6, 2026 β TNON rises 0.4% to $3.71
- Closed at $3.71, +0.41% vs the prior close of $3.70. Day range $3.62β$3.82, opened at $3.80.
- Volume was 422.70K shares, 0.1x its 50-day average of 8.18M β lighter than usual.
- Price is -26.2% vs its 50-day average ($5.04) and -81.5% vs its 200-day average ($20.04).
- 52-week range $2.40β$50.40; today's close sits at 3% of that range, 92.6% below the 52-week high.
Oct 5, 2026 β TNON ends flat (+0.0%) to $3.70, 3 down days in a row
- Closed at $3.70, +0.00% vs the prior close of $3.70. Day range $3.52β$3.82, opened at $3.55.
- Volume was 455.00K shares, 0.1x its 50-day average of 8.17M β lighter than usual.
- Price is -27.3% vs its 50-day average ($5.09) and -81.7% vs its 200-day average ($20.21).
- 52-week range $2.40β$50.40; today's close sits at 3% of that range, 92.7% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: S-3.
Oct 2, 2026 β TNON slides 8.4% to $3.70
- Closed at $3.70, -8.42% vs the prior close of $4.04. Day range $3.65β$4.65, opened at $4.50.
- Volume was 5.89M shares, 0.7x its 50-day average of 8.05M.
- Price is -28.1% vs its 50-day average ($5.15) and -81.8% vs its 200-day average ($20.38).
- 52-week range $2.40β$50.40; today's close sits at 3% of that range, 92.7% below the 52-week high.
TNON latest news & SEC filings
Every SEC filing by or about TNON in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 Β· Form 424B5 β Prospectus supplement
Prospectus supplement β the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 9, 2026 Β· Form EFFECT β EFFECT filing
EFFECT filing
Oct 9, 2026 Β· Form 424B3 β Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 9, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Oct 5, 2026 Β· Form S-3 β Shelf registration (S-3)
Shelf registration (S-3) β lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 16, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
- Item 3.02 β Sold unregistered shares.
- Item 8.01 β Reported other events the company considers important.
Sep 11, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Hrt Financial Lp sold 65,582 shares at $5.56 (β$364.64K) on Sep 10, 2026
- Hrt Financial Lp bought 8,431 shares at $4.92 (β$41.48K) on Sep 10, 2026
- Hrt Financial Lp bought 28,267 shares at $4.02 (β$113.63K) on Sep 10, 2026
- Hrt Financial Lp bought 31,227 shares at $2.92 (β$91.18K) on Sep 10, 2026
- Hrt Financial Lp sold 65,582 shares at $5.56 (β$364.64K) on Sep 10, 2026
- Hrt Financial Lp bought 8,431 shares at $4.92 (β$41.48K) on Sep 10, 2026
- β¦plus 19 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 9, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 8.01 β Reported other events the company considers important.
Sep 8, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 Β· Form 424B3 β Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 4, 2026 Β· Form EFFECT β EFFECT filing
EFFECT filing
Sep 3, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade TNON
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 19, 2026, Feb 6, 2026. Based on that rhythm, the next report is likely around Nov 12, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 7.32% (largest 49.8%). That is a volatile stock.
- Liquidity: about 3.38M shares (β$9.12M) trade per day on average.
- 52-week position: $2.70 vs a range of $2.40β$50.40 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:35 on Aug 10, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 15 open-market buys, 10 sales; latest: Financial Lp Hrt sold 65,582 shares on Sep 10, 2026.
- Latest filings: 8-K Sep 16, 2026; 8-K Sep 9, 2026; 8-K Aug 31, 2026.
- Share count: 667.05K shares outstanding (Aug 13, 2026), -92.5% vs a year earlier β the company has been reducing its share count.
- Listing: Nasdaq Β· industry: Surgical & Medical Instruments & Apparatus.
TNON market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.95 | 3.05 | 2.67 | 2.70 | 210.69K |
| Oct 15, 2026 | 2.83 | 2.93 | 2.78 | 2.91 | 149.90K |
| Oct 14, 2026 | 2.82 | 2.94 | 2.80 | 2.82 | 157.10K |
| Oct 13, 2026 | 2.98 | 3.10 | 2.85 | 2.89 | 225.90K |
| Oct 12, 2026 | 3.34 | 3.36 | 2.95 | 2.98 | 262.70K |
| Oct 9, 2026 | 3.41 | 3.52 | 3.37 | 3.41 | 129.90K |
| Oct 8, 2026 | 3.46 | 3.58 | 3.42 | 3.44 | 111.10K |
| Oct 7, 2026 | 3.58 | 3.64 | 3.38 | 3.50 | 355.00K |
| Oct 6, 2026 | 3.80 | 3.82 | 3.62 | 3.71 | 422.70K |
| Oct 5, 2026 | 3.55 | 3.82 | 3.52 | 3.70 | 455.00K |
| Oct 2, 2026 | 4.50 | 4.65 | 3.65 | 3.70 | 5.89M |
| Oct 1, 2026 | 3.94 | 4.18 | 3.65 | 4.04 | 2.09M |
| Sep 30, 2026 | 2.80 | 5.04 | 2.75 | 4.09 | 53.28M |
| Sep 29, 2026 | 2.80 | 2.88 | 2.67 | 2.73 | 279.00K |
| Sep 28, 2026 | 3.03 | 3.05 | 2.86 | 2.86 | 191.00K |
| Sep 25, 2026 | 2.95 | 3.18 | 2.94 | 3.13 | 1.73M |
| Sep 24, 2026 | 3.18 | 3.27 | 2.95 | 2.96 | 360.20K |
| Sep 23, 2026 | 3.36 | 3.42 | 3.25 | 3.27 | 210.10K |
| Sep 22, 2026 | 3.63 | 3.66 | 3.41 | 3.43 | 560.80K |
| Sep 21, 2026 | 4.04 | 4.08 | 3.70 | 3.73 | 518.80K |
About Tenon Medical
Tenon Medical (TNON) is listed on the Nasdaq and classified by the SEC under βSurgical & Medical Instruments & Apparatusβ. Its business address is in LOS GATOS, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1560293.
TNON board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Steven M Foster | CEO and President | Aug 4, 2026 |
| Richard Ferrari | Director | Aug 4, 2026 |
| Richard Ginn | Chief Technology Officer | Aug 4, 2026 |
| Ivan Howard | Director | Aug 4, 2026 |
| Stephen Hochschuler | Director | Aug 4, 2026 |
| Kristine M Jacques | Director | Aug 4, 2026 |
| Robert K Weigle | Director | Aug 4, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Steven M Foster | CEO and President | Aug 4, 2026 |
| Richard Ginn | Chief Technology Officer | Aug 4, 2026 |
| Wyatt D. Geist | Chief Innovation Officer | May 5, 2026 |
| Nathaniel A. Grawey | Chief Commercial Officer | May 5, 2026 |
| Kevin Williamson | Chief Financial Officer | Sep 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 10, 2026 | Financial Lp Hrt | Sale | 65,582 | $5.56 |
| Sep 10, 2026 | Financial Lp Hrt | Buy | 8,431 | $4.92 |
| Sep 10, 2026 | Financial Lp Hrt | Buy | 28,267 | $4.02 |
| Sep 10, 2026 | Financial Lp Hrt | Buy | 31,227 | $2.92 |
| Sep 10, 2026 | Financial Lp Hrt | Sale | 65,582 | $5.56 |
| Sep 10, 2026 | Financial Lp Hrt | Buy | 8,431 | $4.92 |
| Sep 10, 2026 | Financial Lp Hrt | Buy | 28,267 | $4.02 |
| Sep 10, 2026 | Financial Lp Hrt | Buy | 31,227 | $2.92 |
| Sep 10, 2026 | Financial Lp Hrt | Sale | 65,582 | $5.56 |
| Sep 10, 2026 | Financial Lp Hrt | Buy | 8,431 | $4.92 |
| Sep 10, 2026 | Financial Lp Hrt | Buy | 28,267 | $4.02 |
| Sep 10, 2026 | Financial Lp Hrt | Buy | 31,227 | $2.92 |
| Sep 10, 2026 | Financial Lp Hrt | Sale | 65,582 | $5.56 |
| Sep 10, 2026 | Financial Lp Hrt | Buy | 8,431 | $4.92 |
| Sep 10, 2026 | Financial Lp Hrt | Buy | 28,267 | $4.02 |
TNON financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $3.94M | $-12.56M | -1.70 | $-10.74M |
| Dec 31, 2024 | $3.28M | $-13.67M | -11.26 | $-9.88M |
| Dec 31, 2023 | $2.93M | $-15.58M | -68.64 | $-12.18M |
| Dec 31, 2022 | $691.00K | $-18.92M | -23.62 | $-12.03M |
| Dec 31, 2021 | $160.00K | $-7.05M | -7.81 | $-4.29M |
Latest balance sheet: total assets $9.92M, total liabilities $11.66M, cash $1.68M (as of Jun 30, 2026).
TNON earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $5.96 |
| May 12, 2026 | 8-K Item 2.02 (results) | $28.49 |
| Mar 19, 2026 | 8-K Item 2.02 (results) | $29.23 |
| Feb 6, 2026 | 8-K Item 2.02 (results) | $23.49 |
| Mar 14, 2024 | 8-K Item 2.02 (results) | β |
| Jun 7, 2022 | 8-K Item 2.02 (results) | β |
Related stocks Β· Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on TNON
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.